These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 19389064)

  • 1. Enzymatic characterisation of clinical isolates of Cryptococcus neoformans, Cryptococcus gattii and other environmental Cryptococcus spp.
    Chan MY; Tay ST
    Mycoses; 2010 Jan; 53(1):26-31. PubMed ID: 19389064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil.
    Andrade-Silva L; Ferreira-Paim K; Mora DJ; Da Silva PR; Andrade AA; Araujo NE; Pedrosa AL; Silva-Vergara ML
    Med Mycol; 2013 Aug; 51(6):635-40. PubMed ID: 23343452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental isolation of Cryptococcus neoformans and Cryptococcus gattii from living trees in Guindy National Park, Chennai, South India.
    Girish Kumar CP; Prabu D; Mitani H; Mikami Y; Menon T
    Mycoses; 2010 May; 53(3):262-4. PubMed ID: 19389069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
    Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
    Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.
    Chowdhary A; Rhandhawa HS; Prakash A; Meis JF
    Crit Rev Microbiol; 2012 Feb; 38(1):1-16. PubMed ID: 22133016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
    Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
    Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.
    Feng X; Yao Z; Ren D; Liao W; Wu J
    FEMS Yeast Res; 2008 Sep; 8(6):930-8. PubMed ID: 18671745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
    Khan ZU; Randhawa HS; Chehadeh W; Chowdhary A; Kowshik T; Chandy R
    Int J Antimicrob Agents; 2009 Jun; 33(6):559-63. PubMed ID: 19195846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
    Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
    Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecological surveys of the Cryptococcus species complex in China.
    Li AS; Pan WH; Wu SX; Hideaki T; Guo NR; Shen YN; Lu GX; Pan RG; Zhu MC; Chen M; Shi WM; Liao WQ
    Chin Med J (Engl); 2012 Feb; 125(3):511-6. PubMed ID: 22490412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of clinical isolates of the Cryptococcus neoformans-Cryptococcus gattii species complex from the Amazonas State in Brazil.
    Da Silva BK; Freire AK; Bentes Ados S; Sampaio Ide L; Santos LO; Dos Santos MS; De Souza JV
    Rev Iberoam Micol; 2012; 29(1):40-3. PubMed ID: 21699993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterisation of clinical Cryptococcus neoformans and Cryptococcus gattii isolates from Sichuan province, China.
    Wu SY; Lei Y; Kang M; Xiao YL; Chen ZX
    Mycoses; 2015 May; 58(5):280-7. PubMed ID: 25808662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotype characterization of environmental Cryptococcus neoformans isolates].
    Huérfano S; Cepero MC; Castañeda E
    Biomedica; 2003 Sep; 23(3):328-40. PubMed ID: 14582336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcus neoformans var. gattii in India.
    Padhye AA; Chakrabarti A; Chander J; Kaufman L
    J Med Vet Mycol; 1993; 31(2):165-8. PubMed ID: 8509953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions.
    Kwon-Chung KJ; Bennett JE
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Jul; 257(2):213-8. PubMed ID: 6207684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and association between environmental and clinical isolates of Cryptococcus neoformans in Bogotá-Colombia, 2012-2015.
    Vélez N; Escandón P
    Mem Inst Oswaldo Cruz; 2016 Oct; 111(10):642-648. PubMed ID: 27706379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic diversity of environmental Cryptococcus neoformans isolates from Northern Portugal.
    Ferreira AS; Sampaio A; Maduro AP; Silva I; Teles F; Martins Mda L; Inácio J
    Mycoses; 2014 Feb; 57(2):98-104. PubMed ID: 23848429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic characterization of clinical and environmental Cryptococcus neoformans strains isolated in Italy.
    Pini G; Faggi E; Campisi E
    Rev Iberoam Micol; 2017; 34(2):77-82. PubMed ID: 28215482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for identification of Cryptococcus neoformans and Cryptococcus gattii useful in resource-limited settings.
    Ogundeji AO; Albertyn J; Pohl CH; Sebolai OM
    J Clin Pathol; 2016 Apr; 69(4):352-7. PubMed ID: 26598625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.